Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals

Further Publications Rheumatology

Work-related physical strain as novel risk factor for the severity of joint inflammation at diagnosis of anti-citrullinated protein antibodies positive rheumatoid arthritis

Rheumatology (Oxford)

Ton DA, van Dijk BT, van Steenbergen HW, van der Helm-van Mil AHM

doi: 10.1093/rheumatology/keag009

Rheumatoid Arthritis

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial

Lancet Rheumatol

Cope AP, Jasenecova M, Vasconcelos JC, Qureshi S, van Schie KA, Filer A, Raza K, D'Agostino MA, McInnes IB, Siebert S, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Mankia K, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga TWJ, Toes REM, Georgiou E, Kelly J, Murphy C, Prevost AT, ALTO Study Investigators

doi: 10.1016/S2665-9913(25)00371-6

Rheumatoid Arthritis

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Ann Rheum Dis

van Steenbergen HW, Doornkamp F, Alivernini S, Backlund J, Codreanu C, Cohen SB, Combe B, Cope AP, Deane KD, England BR, Falahee M, de Jong PHP, Kleyer A, Lacaille D, Maat B, Mankia K, van Mulligen E, Nagy G, O'Neil LJ, Rodamaker L, Sahbudin I, van Schaardenburg D, Sepriano A, da Silva JAP, De Smet L, Sparks JA, Steyerberg EW, Studenic P, Wethington E, Landewé RL, Raza K, van der Helm-van Mil AHM

doi: 10.1016/j.ard.2025.01.021

Rheumatoid Arthritis

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Semin Arthritis Rheum

Gazel U, Barnes E, Jones B, Terrett A, Voshaar M, Hoogland W, March L, Beaton D, Khoo T, Chin A, Shea B, Tugwell P, Proudman S, Flurey CA

doi: 10.1016/j.semarthrit.2026.152948

Rheumatoid Arthritis

Quantified intakes of key diet components and the risk of developing rheumatoid arthritis: Results from a nested case-control study

Ann Rheum Dis

Bäcklund R, Bergström U, Compagno M, Arvidsson L, Rydell E, Sonestedt E, Turesson C

doi: 10.1016/j.ard.2025.06.2123

Rheumatoid Arthritis

Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis

Arthritis Care Res (Hoboken)

McMenamin KJ, Riley TR 4th, Wipfler K, Michaud K, Wheeler A, England BR, Sauer B, Wysham KD, Xiao R, March M, Cannon GW, Toikumo S, Kranzler HR, Kember RL, Mikuls TR, Baker JF

doi: 10.1002/acr.25588

Rheumatoid Arthritis

Association between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients with Rheumatoid Arthritis

Arthritis Care Res (Hoboken)

Lin CP, Aydemir B, Song J, Muhammad LN, Neogi T, Marder W, Bingham CO, Bolster MB, Clauw DJ, Dunlop DD, Lee YC

doi: 10.1002/acr.25668

Rheumatoid Arthritis

Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Arthritis Rheumatol

Liu J, Li Y, Fu K, Wu C, Schafer P, Connolly SE, Catlett IM, Maldonado MA, Wong R, Emery P, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TWJ, Fleischmann R

doi: 10.1002/art.70106

Juvenile Idiopathic Arthritis

Cataract surgery with IOL implantation in children with chronic anterior uveitis associated with juvenile idiopathic arthritis (JIA) or antinuclear antibody (ANA)-positive uveitis: mid-term results and predictors for outcome

Am J Ophthalmol

Wortmann C, Backes J, Rothaus K, Kasper M, Lapp T, Heinz C, Heiligenhaus A

doi: 10.1016/j.ajo.2025.11.043

Related content

Work-related physical strain as novel risk factor for the severity of joint inflammation at diagnosis of anti-citrullinated protein antibodies positive rheumatoid arthritis

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Quantified intakes of key diet components and the risk of developing rheumatoid arthritis: Results from a nested case-control study

Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis

Association between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients with Rheumatoid Arthritis

Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Cataract surgery with IOL implantation in children with chronic anterior uveitis associated with juvenile idiopathic arthritis (JIA) or antinuclear antibody (ANA)-positive uveitis: mid-term results and predictors for outcome